Alexander JJ - Search Results

1

Development of a Prospective Real-World Data Clinical Registry of Children and Adolescents With Migraine.

Hornik CP, Gelfand AA, Szperka CL, Pezzuto T, Utevsky A, Kessel S, McCune S, Alexander JJ, Benjamin DK Jr, Cohen-Wolkowiez M. Hornik CP, et al. Among authors: alexander jj. Headache. 2020 Feb;60(2):405-415. doi: 10.1111/head.13714. Epub 2019 Nov 22. Headache. 2020. PMID: 31758549 Free PMC article.

2

Exposure-Response Assessment in Pediatric Drug Development Studies Submitted to the US Food and Drug Administration.

Zhang Y, Wang Y, Khurana M, Sachs HC, Zhu H, Burckart GJ, Alexander J, Yao LP, Wang J. Zhang Y, et al. Clin Pharmacol Ther. 2020 Jul;108(1):90-98. doi: 10.1002/cpt.1809. Epub 2020 Mar 16. Clin Pharmacol Ther. 2020. PMID: 32030741

3

Considerations and Challenges in the Remdesivir COVID-19 Pediatric Development Program.

Chan-Tack K, Sampson M, Earp J, Arya V, Yao L, Alexander J, Hausman E, Belew Y, Birnkrant D, Struble K. Chan-Tack K, et al. J Clin Pharmacol. 2023 Feb;63(2):259-265. doi: 10.1002/jcph.2158. Epub 2022 Oct 4. J Clin Pharmacol. 2023. PMID: 36149807 Free PMC article.

4

Evaluation of FDA Labeling Changes Related to PREA Safety-Waivers.

Krastein J, Pica-Branco D, Bacho MA, Mulugeta Y, Maynard JW, Alexander JJ, Yao L, Hausman ED. Krastein J, et al. Among authors: alexander jj. Ther Innov Regul Sci. 2023 Sep;57(5):1099-1103. doi: 10.1007/s43441-023-00551-z. Epub 2023 Jun 30. Ther Innov Regul Sci. 2023. PMID: 37389793

5

Amoxicillin for postexposure inhalational anthrax in pediatrics: rationale for dosing recommendations.

Alexander JJ, Colangelo PM, Cooper CK, Roberts R, Rodriguez WJ, Murphy MD. Alexander JJ, et al. Pediatr Infect Dis J. 2008 Nov;27(11):955-7. doi: 10.1097/INF.0b013e31817bf9a9. Pediatr Infect Dis J. 2008. PMID: 18833025

6

Choice and doses of antibacterial agents for cement spacers in treatment of prosthetic joint infections: review of published studies.

Iarikov D, Demian H, Rubin D, Alexander J, Nambiar S. Iarikov D, et al. Clin Infect Dis. 2012 Dec;55(11):1474-80. doi: 10.1093/cid/cis735. Epub 2012 Aug 23. Clin Infect Dis. 2012. PMID: 22918993 Review.

7

Hypersensitivity reactions associated with fidaxomicin use.

Iarikov DE, Alexander J, Nambiar S. Iarikov DE, et al. Clin Infect Dis. 2014 Feb;58(4):537-9. doi: 10.1093/cid/cit719. Epub 2013 Oct 30. Clin Infect Dis. 2014. PMID: 24178248

8

Cardiovascular risks with azithromycin and other antibacterial drugs.

Mosholder AD, Mathew J, Alexander JJ, Smith H, Nambiar S. Mosholder AD, et al. Among authors: alexander jj. N Engl J Med. 2013 May 2;368(18):1665-8. doi: 10.1056/NEJMp1302726. N Engl J Med. 2013. PMID: 23635046 Free article. No abstract available.

9

Optimising piperacillin/tazobactam dosing in paediatrics.

Tornøe CW, Tworzyanski JJ, Imoisili MA, Alexander JJ, Korth-Bradley JM, Gobburu JV. Tornøe CW, et al. Among authors: alexander jj. Int J Antimicrob Agents. 2007 Oct;30(4):320-4. doi: 10.1016/j.ijantimicag.2007.05.014. Epub 2007 Jul 13. Int J Antimicrob Agents. 2007. PMID: 17631983

10

Pediatric formulation development - Challenges of today and strategies for tomorrow: Summary report from M-CERSI workshop 2019.

Tan DCT, Khong YM, Mount S, Galella E, Mitra B, Charlton S, Kuhli M, Ternik R, Walsh J, Rajapakshe A, Thompson K, Mehrotra S, Santangelo M, Liu J, Dixit T, Schaufelberger D, Jamzad S, Klein S, Hoag SW, Wang J, Fletcher EP, Khurana M, Alexander J, Radden E, Sood R, Selen A. Tan DCT, et al. Eur J Pharm Biopharm. 2021 Jul;164:54-65. doi: 10.1016/j.ejpb.2021.04.011. Epub 2021 Apr 18. Eur J Pharm Biopharm. 2021. PMID: 33878432

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters